Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FG4AL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,900
Award facts
- Contract value 100% obligated
- $18,900.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $18,900.01 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pen injections on June 2, 2025, with completion targeted for June 3, 2025. This firm fixed-price contract, which carries no set-aside designation, was competitively awarded and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The pharmaceutical will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor, AmerisourceBergen maintains a comprehensive federal contracting portfolio supplying medications, vaccines, and medical devices across multiple therapeutic domains to military and veteran healthcare systems.
This delivery order falls within the broader context of AmerisourceBergen's $999,999,999.00 IDC with DLA Troop Support Medical, which extends through December 2026 and serves as a global pharmaceutical support vehicle for military healthcare programs. The contract enables the company to supply specialty medications and medical commodities to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The award demonstrates AmerisourceBergen's ongoing role as a critical vendor in the federal medical supply chain, with the company positioned to continue supporting DLA's pharmaceutical procurement needs under this comprehensive contract structure.
Quick answers
Who was awarded contract SPE2DB25FG4AL?
SPE2DB25FG4AL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 2, 2025.
How much is contract SPE2DB25FG4AL worth?
The government has obligated $18,900 on SPE2DB25FG4AL.
Is contract SPE2DB25FG4AL an order under another contract?
Yes. SPE2DB25FG4AL is a delivery order under SPE2DB22D1017, an indefinite delivery contract.
Was contract SPE2DB25FG4AL competed?
The extent of competition for SPE2DB25FG4AL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award